The appointment of PwC in replacement of KPMG has been approved by the
Company's Audit Committee and the Board of Directors. Upon the appointment,
PwC will commence the annual audit work and is working with the Company and
KPMG to ensure a seamless transition. PwC has communicated with the Company's
Audit Committee and the independent law firm engaged by the Audit Committee
regarding the recent independent internal investigation before accepting this
appointment. The Company expects to meet the deadline of filing its annual
report on Form 20-F for the fiscal year ended
"We would like to thank KPMG for their dedicated service over the past
five years," said Mr.
The Company and KPMG have not had any disagreement on matters of accounting principles or practices, financial statement disclosure, or auditing scope or procedures for which disagreement, if not resolved to the satisfaction of KPMG, would have caused KPMG to make reference to the subject matter of the disagreement in connection with its report on the Company's consolidated financial statements.
About China Medical Technologies, Inc.
China Medical Technologies is a leading
Safe Harbor Statement
This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.
For more information, please contact: Sam Tsang Tel: +852-2511-9808 Email: IR@chinameditech.com
SOURCE China Medical Technologies, Inc.